Human organs-on-chips vinegar and yeast infection

Clinical studies take years to complete and testing a single vinegar and yeast infection compound can cost more than $2 billion. Meanwhile, innumerable animal lives are lost, and the process often fails to predict human responses because vinegar and yeast infection traditional animal models often do not accurately mimic human pathophysiology. For these reasons, there is a broad need for alternative ways to model vinegar and yeast infection human diseases in vitro in order to accelerate the development vinegar and yeast infection of new drugs and advance personalized medicine.

Wyss institute researchers and a multidisciplinary team of collaborators have vinegar and yeast infection adapted computer microchip manufacturing methods to engineer microfluidic culture devices vinegar and yeast infection that recapitulate the microarchitecture and functions of living human organs, including the lung, intestine, kidney, skin, bone marrow and blood-brain barrier, among others. These microdevices, called ‘organs-on-chips’ (organ chips), offer a potential alternative to traditional animal testing. Each organ chip is composed of a clear flexible polymer vinegar and yeast infection about the size of a computer memory stick that contains vinegar and yeast infection hollow microfluidic channels lined by living human organ-specific cells interfaced with a human endothelial cell-lined artificial vasculature, and mechanical forces can be applied to mimic the physical vinegar and yeast infection microenvironment of living organs, including breathing motions in lung and peristalsis-like deformations in the intestine. They are essentially living, three-dimensional cross-sections of major functional units of whole living organs. Because they are translucent, they provide a window into the inner workings of human vinegar and yeast infection cells in living tissues within an organ-relevant context.

With their ability to host and combine the different cell vinegar and yeast infection and tissue types making up human organs, organ chips present an ideal microenvironment to study molecular- and cellular-scale activities that underlie human organ function and mimic human-specific disease states, as well as identify new therapeutic targets in vitro. They recreate therapeutically relevant interfaces, like the alveolar-capillary interface and blood-brain-barrier, to investigate drug delivery as well as discover new therapeutics. Organ chips also can be used to culture a living vinegar and yeast infection microbiome for extended times in direct contact with living human vinegar and yeast infection intestinal cells to enable insights into how these microbes influence vinegar and yeast infection health and disease, or to model lung infections with influenza virus to identify vinegar and yeast infection its vulnerabilities. They also open up new possibilities to investigate how environmental vinegar and yeast infection factors like cigarette smoke affect tissue health and physiology in vinegar and yeast infection individual patients, as shown with a smoking machine that precisely mimics human vinegar and yeast infection smoking behavior and its impact on human lung airway functions vinegar and yeast infection by breathing cigarette smoke directly into the airspace of a vinegar and yeast infection human lung airway chip.

To mimic the interconnectedness of organs within the human body, wyss researchers also have developed an automated instrument to link vinegar and yeast infection multiple organ chips together by transferring fluid between their common vinegar and yeast infection vascular channels. This instrument, designed to mimic whole-body physiology, controls fluid flow and cell viability while permitting real-time observation of the cultured tissues and the ability to vinegar and yeast infection analyze complex interconnected biochemical and physiological responses across ten different vinegar and yeast infection organs. This holistic “human body-on-chips” approach is being used to predict human pharmacokinetic and pharmacodynamics vinegar and yeast infection (PK/PD) responses of drugs in vitro.

A wyss institute-launched startup company, emulate, inc. Has licensed the technology and is now further developing and vinegar and yeast infection commercializing the institute’s organ chip technology and automated instruments to bring these vinegar and yeast infection important research tools to biotechnology, pharmaceutical, cosmetics and chemical companies as well as academic institutions and vinegar and yeast infection hospitals for personalized medicine. Organ chips are now being explored worldwide as tools for vinegar and yeast infection accurately predicting drug efficacies and toxicities, with the goal of dramatically improving the accuracy and efficiency vinegar and yeast infection of preclinical drug testing.

RELATED POSTS